Obesity and diabetes linked to heart disease can also affect the incidence and severity of cancer, a collection of four new studies suggests.
Read More »Depression Treatment Reduces Mortality by Half in Older Diabetics
Older depressed patients with diabetes who receive additional intervention for their depression are half as likely to die within 5 years as similar patients who not provided this intervention
Read More »Calling Couch Potatoes, Works!
Fitness research shows that when a computer talks the talk, even couch potatoes can be persuaded to walk the walk.
Read More »Prevention in the “Real World”: One-year Results of the GOAL Implementation Trial
A lifestyle implementation trial was designed for the primary care setting. The goal was to determine whether findings from the Finnish Diabetes Prevention Study (DPS),[1] which demonstrated a 58% reduction in diabetes with lifestyle intervention, could be replicated in a real-world clinical setting.
Read More »Eating Disturbance Common in Girls With Type 1 Diabetes
There is a high prevalence of eating disorders among girls with type 1 diabetes according to Canadian researchers. They also found that eating disturbances in this population are likely to persist over time.
Read More »Insulin Detemir Safer Than NPH in Elderly Type 2’s
In patients older than 65 with type 2 diabetes requiring insulin, insulin detemir may be a better choice than NPH insulin, based on an analysis of pooled data from randomized studies.In patients older than 65 with type 2 diabetes requiring insulin, insulin detemir may be a better choice than NPH …
Read More »Insulin Reduces Mortality in Patients With ACS and Hyperglycemia
Insulin treatment of nondiabetic patients with acute coronary syndrome (ACS) and hyperglycemia is associated with reduced risk of death in the first 30 days.
Read More »Adults With Conditions that Increase Cardiovascular Disease Risk Have High Blood Pressure
Nearly three-fourths of American adults with conditions such as coronary heart disease, stroke, diabetes or others that raise their risk for cardiovascular complications also have hypertension (high blood pressure).
Read More »FDA Approves Diovan® for Treatment of High Blood Pressure in Children
Diovan® (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) for the treatment of high blood pressure in children and adolescents ages six to 16.
Read More »Vinegar at Bedtime Can Benefit Type 2’s
A dose of vinegar taken at bedtime may favorably impact waking glucose concentrations in patients with type 2 diabetes, comes from the results of a new study.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.